how to switch from semaglutide to tirzepatide Conversion semaglutide: dosing, timing & results (2026) Switching Between Semaglutide and Tirzepatide:

If you want to better understand how support fits into that process, our article on GLP-1 support and how it can transform your weight loss journey is a useful companion read

It is important to emphasise that Phase 2 results are exploratory and involve smaller patient populations than Phase 3 trials

Ioannidou: [00:44:12] Oh, great

On June 27, 2025, Innovent Biologics, Inc., a leading biopharmaceutical company focused on developing, manufacturing, and commercializing high-quality medicines for oncology, autoimmune, cardiovascular, and metabolic diseases, announced that China's National Medical Products Administration (NMPA) approved Mazdutide, the worlds first dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, for chronic weight management in Chinese adults with overweight or obesity